Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020)
Neurocrine Biosciences (NBIX) reported Change in Working Capital of $4.1 million for Q1 2020, up 224.24% on a YoY basis from $1.3 million in Q2 2019, and up 224.24% quarter-over-quarter from -$3.3 million in Q1 2019.
Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020) Analysis & Trends
Neurocrine Biosciences has reported Change in Working Capital for 2 years, with the latest figure at $4.1 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -617.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2019 | -3.30 Mn |
| Mar 31, 2019 | -3.30 Mn |